0903 GMT - Allianz Health is a growth engine within the German insurer, Keefe, Bruyette & Woods says in a research note. The unit includes the non-life and life divisions for external reporting purposes but is a clearer third silo internally. It has historically delivered double-digit operating profit growth, which it seems management hopes to maintain, analyst William Hawkins writes. The division has the potential for structural growth, the analyst says. It has seen margin improvement in its core European markets and growth in mostly Asian developing economies, which the insurer has flagged as markets with high growth potential, he notes. Shares trade at 344.2 euros and have risen 16% since the start of the year. (elena.vardon@wsj.com)
(END) Dow Jones Newswires
June 30, 2025 05:03 ET (09:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.